Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Crystalline κ-light-chain proximal tubulopathy in Waldenström macroglobulinemia with an IgA nephropathy pattern: a case report and systematic review

  1. 1Department of Nephrology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University
  2. 2The School of Clinical Medicine, Fujian Medical University
  3. 3Nanjing Kingmed Center for Clinical Laboratory

Abstract

Light-chain proximal tubulopathy (LCPT) is a rare renal manifestation of monoclonal gammopathy that is exceptionally uncommon in Waldenström macroglobulinemia (WM). We report a case of crystalline κ-LCPT in WM and conduct a literature review of WM-associated LCPT and crystal-storing histiocytosis (CSH). A 65-year-old man with a 4-year history of intermittent hematuria and proteinuria developed progressive renal dysfunction. Before admission, myeloperoxidase (MPO)-anti-neutrophil cytoplasmic antibody (ANCA) was strongly positive by qualitative immunoblotting, initially raising concern for ANCA-associated vasculitis. After admission, repeat testing on a separate sample showed only modest MPO-ANCA elevation by chemiluminescence, whereas proteinase 3 (PR3)-ANCA and both P-ANCA and C-ANCA by indirect immunofluorescence were negative; serum immunoglobulin M (IgM) was markedly elevated, and monoclonal IgM-κ was identified in serum and urine. Kidney biopsy demonstrated crystalline κ-LCPT, with κ-predominant light-chain staining in proximal tubular epithelial cells and organized intracytoplasmic crystals on electron microscopy. Concurrent glomerular findings showed an immunoglobulin A (IgA) nephropathy pattern, characterized by strong mesangial IgA/C3 deposition, polytypic glomerular κ and λ staining without light-chain restriction, and corresponding electron-dense deposits. The biopsy showed no active pauci-immune necrotizing or cellular crescentic glomerulonephritis, arguing against ANCA-mediated renal injury. Crystalline material was also identified ultrastructurally within interstitial mononuclear cells, raising but not confirming CSH because histiocytic lineage was not verified by CD68/CD163. Bone marrow examination established WM/LPL with MYD88-L265P positivity. MYD88-L265P places the underlying lymphoplasmacytic clone within the canonical MYD88–interleukin-1 receptor-associated kinase (IRAK)–Bruton tyrosine kinase (BTK)–nuclear factor κB (NF-κB) signaling axis of WM. The discordant MPO-ANCA serology was considered more likely to represent non-specific/paraprotein-associated assay reactivity. Sequential BTK inhibitor therapy (ibrutinib followed by zanubrutinib, with the temporary addition of bortezomib–dexamethasone) achieved sustained hematological response and stable renal function over 49 months of follow-up. Our literature review identified seven eligible published WM-associated LCPT and/or CSH cases, yielding eight cases including the present patient. This case expands the spectrum of WM-associated renal disease by highlighting crystalline κ-LCPT as a rare clone-related tubular lesion and underscores the importance of integrated renal pathological and hematological evaluation in distinguishing clone-related injury from coexisting renal lesions.

Related

  1. B-cell modulators in immunoglobulin A nephropathy
    Arun Rajasekaran, Jan Novak, Dana V. Rizk
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  2. Canonical correlation analysis identifies single nucleotide polymorphism combinations and gene expression associated with membranous nephropathy
    Amy J. Osborne, Samantha Hayward, Elizabeth Colby +9
    Communications BiologyPeer-reviewedCC BY 4.0General biologyCrossref
  3. Dysbiosis of the commensal microbiota in IgA nephropathy
    Sho Hamaguchi, Yusuke Suzuki, Wataru Suda
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiers
  4. Successful treatment of anti-glomerular basement membrane antibody disease combined with membranous nephropathy using rituximab: a case report
    Yaqian Cheng, Guojian Shao, LingJiu Shao +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossref
  5. Case Report: Clinical insights into IgG4-related nephropathy with overlapping syndrome: a review of two cases
    Zhimei Peng, Hengshuang Yang, Ziqing Yue +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
BibTeX
@article{zhang2026crystalline,
  title = {{Crystalline κ-light-chain proximal tubulopathy in Waldenström macroglobulinemia with an IgA nephropathy pattern: a case report and systematic review}},
  author = {Jun Zhang and Xing Chen and Lijing Yao and Tiekun Li and Xuejuan Sun and Xiuhua Xu and Peijin Bai and Leping Shao and Juan Pei},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1942324},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1942324/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Crystalline κ-light-chain proximal tubulopathy in Waldenström macroglobulinemia with an IgA nephropathy pattern: a case report and systematic review
AU  - Jun Zhang
AU  - Xing Chen
AU  - Lijing Yao
AU  - Tiekun Li
AU  - Xuejuan Sun
AU  - Xiuhua Xu
AU  - Peijin Bai
AU  - Leping Shao
AU  - Juan Pei
PY  - 2026
DA  - 2026/10/15
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1942324
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1942324/full
AB  - Light-chain proximal tubulopathy (LCPT) is a rare renal manifestation of monoclonal gammopathy that is exceptionally uncommon in Waldenström macroglobulinemia (WM). We report a case of crystalline κ-LCPT in WM and conduct a literature review of WM-associated LCPT and crystal-storing histiocytosis (CSH). A 65-year-old man with a 4-year history of intermittent hematuria and proteinuria developed progressive renal dysfunction. Before admission, myeloperoxidase (MPO)-anti-neutrophil cytoplasmic antibody (ANCA) was strongly positive by qualitative immunoblotting, initially raising concern for ANCA-associated vasculitis. After admission, repeat testing on a separate sample showed only modest MPO-ANCA elevation by chemiluminescence, whereas proteinase 3 (PR3)-ANCA and both P-ANCA and C-ANCA by indirect immunofluorescence were negative; serum immunoglobulin M (IgM) was markedly elevated, and monoclonal IgM-κ was identified in serum and urine. Kidney biopsy demonstrated crystalline κ-LCPT, with κ-predominant light-chain staining in proximal tubular epithelial cells and organized intracytoplasmic crystals on electron microscopy. Concurrent glomerular findings showed an immunoglobulin A (IgA) nephropathy pattern, characterized by strong mesangial IgA/C3 deposition, polytypic glomerular κ and λ staining without light-chain restriction, and corresponding electron-dense deposits. The biopsy showed no active pauci-immune necrotizing or cellular crescentic glomerulonephritis, arguing against ANCA-mediated renal injury. Crystalline material was also identified ultrastructurally within interstitial mononuclear cells, raising but not confirming CSH because histiocytic lineage was not verified by CD68/CD163. Bone marrow examination established WM/LPL with MYD88-L265P positivity. MYD88-L265P places the underlying lymphoplasmacytic clone within the canonical MYD88–interleukin-1 receptor-associated kinase (IRAK)–Bruton tyrosine kinase (BTK)–nuclear factor κB (NF-κB) signaling axis of WM. The discordant MPO-ANCA serology was considered more likely to represent non-specific/paraprotein-associated assay reactivity. Sequential BTK inhibitor therapy (ibrutinib followed by zanubrutinib, with the temporary addition of bortezomib–dexamethasone) achieved sustained hematological response and stable renal function over 49 months of follow-up. Our literature review identified seven eligible published WM-associated LCPT and/or CSH cases, yielding eight cases including the present patient. This case expands the spectrum of WM-associated renal disease by highlighting crystalline κ-LCPT as a rare clone-related tubular lesion and underscores the importance of integrated renal pathological and hematological evaluation in distinguishing clone-related injury from coexisting renal lesions.
SN  - 1664-3224
ER  -